PubRank
Search
About
Lee Silverman
Author PubWeight™ 14.66
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.
Science
2013
5.10
2
Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays.
Clin Cancer Res
2011
2.35
3
HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.
Blood
2003
1.15
4
Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.
Oncogene
2005
1.15
5
Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice.
Exp Neurol
2010
1.08
6
Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.
Retrovirology
2007
1.02
7
Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.
Cancer Res
2010
0.92
8
Enhanced expression of cyclooxygenase-2 in glaucomatous dog eyes.
Vet Ophthalmol
2004
0.79
9
Toxicological protein biomarker analysis--an investigative one-week single dose intravenous infusion toxicity and toxicokinetic study in cynomolgus monkeys using an antibody-cytotoxic conjugate against ovarian cancer.
Pharm Res
2008
0.78
10
Drug safety evaluation through biomarker analysis--a toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer.
Toxicol Appl Pharmacol
2007
0.78
11
Regulatory forum for Toxicologic Pathology: an update.
Toxicol Pathol
2008
0.75